Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash flows from operating activities:
Net income	$ 5,786	$ 360
Adjustments to reconcile net income to cash (used) provided by operating activities:
Depreciation and amortization	1,622	626
Allowance for doubtful accounts	48	48
Value of share-based payment arrangements	162	29
Amortization of deferred finance costs	69	81
Utilization of deferred tax asset	3,422	193
Changes in assets and liabilities (net of acquisition):
Trade accounts receivable	(5,694)	(5,378)
Inventories	(10,497)	6,314
Income taxes receivable	0	2,709
Prepaid and other assets	(4,521)	(4,355)
Accounts payable and accrued expenses	4,104	4,027
Cash (used) provided by operating activities	(5,499)	4,654
Cash flows from investing activities:
Asset acquisitions	(2,424)	0
Additions to patents	(7)	(10)
Additions to property, plant, and equipment	(647)	(534)
Investment in affiliates	0	63
Cash used by investing activities	(3,078)	(481)
Cash flows from financing activities:
Proceeds from issuance of common stock	384	15,639
Proceeds from (repayments of) short-term debt - net	8,580	(15,080)
Proceeds from long-term debt	292	0
Repayment of long-term debt	(243)	(4,228)
Payment of deferred acquisition cost	(331)	0
Cash provided (used) by financing activities	8,682	(3,669)
Increase in cash and cash equivalents	105	504
Cash and cash equivalents at beginning of period	935	669
Cash and cash equivalents at end of period	1,040	1,173
Supplemental Disclosure of Cash Flow Information:
Cash paid during period for interest	531	413
Non cash investing activity:
Deferred acquisition cost	$ 2,669	$ 0